OBJECTIVE AND IMPORTANCE: Symptomatic basilar artery stenosis is a highly morbid disease process. Recent technological and pharmaceutical advances make endovascular treatment of this disease process possible. CLINICAL PRESENTATION: We report three cases of patients with a symptomatic basilar artery stenosis despite anticoagulation. INTERVENTION: All patients were successfully treated with a flexible coronary stent and perioperative antiplatelet medications without incident. Poststenting angiography demonstrated a normal-caliber artery with patent perforators. In one case, a poststenting cerebral blood flow study revealed improved perfusion. CONCLUSION: A new generation of stents and balloons makes access to intracranial intradural arterial pathological abnormalities possible. Such devices may well revolutionize the management of ischemic and hemorrhagic intracranial cerebrovascular disease.
OBJECTIVE AND IMPORTANCE: Symptomatic basilar artery stenosis is a highly morbid disease process. Recent technological and pharmaceutical advances make endovascular treatment of this disease process possible. CLINICAL PRESENTATION: We report three cases of patients with a symptomatic basilar artery stenosis despite anticoagulation. INTERVENTION: All patients were successfully treated with a flexible coronary stent and perioperative antiplatelet medications without incident. Poststenting angiography demonstrated a normal-caliber artery with patent perforators. In one case, a poststenting cerebral blood flow study revealed improved perfusion. CONCLUSION: A new generation of stents and balloons makes access to intracranial intradural arterial pathological abnormalities possible. Such devices may well revolutionize the management of ischemic and hemorrhagic intracranial cerebrovascular disease.
Authors: C C Phatouros; J E Lefler; R T Higashida; P M Meyers; A M Malek; C F Dowd; V V Halbach Journal: AJNR Am J Neuroradiol Date: 2000-10 Impact factor: 3.825
Authors: H J Jaeger; K D Mathias; R Drescher; E Hauth; G Bockisch; E Demirel; H M Gissler Journal: AJNR Am J Neuroradiol Date: 2001-08 Impact factor: 3.825
Authors: Elad I Levy; Jay U Howington; Johnathan A Engh; Ricardo A Hanel; Naveh Levy; Stanley H Kim; Kevin J Gibbons; Lee R Guterman; L Nelson Hopkins Journal: Neurocrit Care Date: 2005 Impact factor: 3.210
Authors: Thomas E Mayer; Gerhard F Hamann; Gernot Schulte-Altedorneburg; Hartmut Brückmann Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825